Ei Expands Capabilities Through KeraNetics Partnership

Ei, A Pharmaceutical SolutionWorks has entered a new partnership with KeraNetics, a biomaterials company focused on creating keratin-based products for use in regenerative medicine and trauma care. Additionally, Ei began a $13.2 million expansion at its recently completed 147,000-sq.-ft. facility in Kannapolis, NC, broadening its manufacturing capabilities. Ei is providing product formulation and development to commercialize KeraNetics’ patented product lines and will manufacture an advanced biomaterial to support the product lines for KeraNetics.

“We are excited to announce our new partnership with KeraNetics,” said Michael Kane, chief executive officer, Ei. “We feel that KeraNetics recognizes our team as product knowledge experts. A relationship of this magnitude showcases the level of skill and technology-driven innovation that exists in the DNA of Ei. Further, it illustrates the intellectual capital Ei brings to the table and taps into the strong business-to-business relationships that we have forged and continue to maintain with our customers. We are not only assisting in the development and manufacturing of exciting new products, but are providing an added value to KeraNetics as a bridge to Ei’s like-minded customers.”

“The relationship with Ei has developed as a result of KeraNetics’ intent to bring these exciting new keratin-based products to market,” said Kim Westmoreland, managing director, KeraNetics. “We were originally looking at building a facility to manufacture these cutting-edge, keratin products which would have involved years of planning and construction. After meeting the leadership team at Ei and touring their state-of-the-art facility we realized that this partnership would allow us to cut those years out of the equation and create access to these products much more quickly. We could not be more pleased.”